MedPath

DEXTROSE 5% AND ELECTROLYTE NO75 INJ

DEXTROSE 5% AND ELECTROLYTE NO75 INJ

Discontinued
DIN Number

00261335

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00261335
AIG Number0500102001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BB02 ELECTROLYTES WITH CARBOHYDRATES
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

DEXTROSEActive
Strength: 5 G / 100 ML
Monograph: DEXTROSE
POTASSIUM CHLORIDEActive
Strength: 205 MG / 100 ML
Monograph: POTASSIUM CHLORIDE
POTASSIUM PHOSPHATE MONOBASICActive
Strength: 100 MG / 100 ML
Monograph: POTASSIUM PHOSPHATE MONOBASIC
SODIUM CHLORIDEActive
Strength: 120 MG / 100 ML
Monograph: SODIUM CHLORIDE
SODIUM LACTATEActive
Strength: 220 MG / 100 ML
Monograph: SODIUM LACTATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.